Glatiramer

Glatiramer is an immunomodulator utilized for the treatment and management of multiple sclerosis. It is grouped under the following drug class(es): Peptides. Its therapeutic use is listed as multiple sclerosis agents. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2 and 6-diaminohexanoic acid. Its PubChem CID is 65370.

CAS No 28704-27-0
Molecular Formula C23H41N5O11
Molecular Weight 563.6 g/mol
Synonyms (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid

Frequently Asked Questions